Endogenous enkephalins and ␦ opiates affect sensory function and pain sensation by inhibiting synaptic transmission in sensory circuits via delta opioid receptors (DORs). DORs have long been suspected of mediating these effects by modulating voltage-dependent Ca 2ϩ entry in primary sensory neurons. However, not only has this hypothesis never been validated in these cells, but in fact several previous studies have only turned up negative results. By using whole-cell current recordings, we show that the ␦ enkephalin analog [D-Ala 2 , D-Leu 5 ]-enkephalin (DADLE) inhibits, via DORs, L-, N-, P-, and Q-high voltageactivated Ca 2ϩ channel currents in cultured rat dorsal root ganglion (DRG) neurons. The percentage of responding cells was remarkably high (75%) within a novel subpopulation of substance P-containing neurons compared with the other cells (18-35%). DADLE (1 M) inhibited 32% of the total barium current through calcium channels (I Ba ). A ␦ (naltrindole, 1 M), but not a (␤-funaltrexamine, 5 M), antagonist prevented the DADLE response, whereas a DOR-2 subtype (deltorphin-II, 100 nM), but not a DOR-1 (DPDPE, 1 M), agonist mimicked the response. L-, N-, P-, and Q-type currents contributed, on average, 18, 48, 14, and 16% to the total I Ba and 19, 50, 26, and 20% to the DADLE-sensitive current, respectively. The druginsensitive R-type current component was not affected by the agonist. This work represents the first demonstration that DORs modulate Ca 2ϩ entry in sensory neurons and suggests that ␦ opioids could affect diverse Ca 2ϩ -dependent processes linked to Ca 2ϩ influx through different high-voltage-activated channel types.
Endogenous enkephalins and ␦ opiates affect sensory function and pain sensation by inhibiting synaptic transmission in sensory circuits via delta opioid receptors (DORs). DORs have long been suspected of mediating these effects by modulating voltage-dependent Ca 2ϩ entry in primary sensory neurons. However, not only has this hypothesis never been validated in these cells, but in fact several previous studies have only turned up negative results. By using whole-cell current recordings, we show that the ␦ enkephalin analog [D-Ala 2 , ]-enkephalin (DADLE) inhibits, via DORs, L-, N-, P-, and Q-high voltageactivated Ca 2ϩ channel currents in cultured rat dorsal root ganglion (DRG) neurons. The percentage of responding cells was remarkably high (75%) within a novel subpopulation of substance P-containing neurons compared with the other cells (18-35%). DADLE (1 M) inhibited 32% of the total barium current through calcium channels (I Ba ). A ␦ (naltrindole, 1 M), but not a (␤-funaltrexamine, 5 M), antagonist prevented the DADLE response, whereas a DOR-2 subtype (deltorphin-II, 100 nM), but not a DOR-1 (DPDPE, 1 M), agonist mimicked the response. L-, N-, P-, and Q-type currents contributed, on average, 18, 48, 14, and 16% to the total I Ba and 19, 50, 26, and 20% to the DADLE-sensitive current, respectively. The druginsensitive R-type current component was not affected by the agonist. This work represents the first demonstration that DORs modulate Ca 2ϩ entry in sensory neurons and suggests that ␦ opioids could affect diverse Ca 2ϩ -dependent processes linked to Ca 2ϩ influx through different high-voltage-activated channel types.
Key words: Ca 2ϩ channel; ␦ opioid receptor; modulation; sensory neuron; dorsal root ganglion; high-voltage-activated Ca 2ϩ current; nimodipine; -conotoxin GVIA; -agatoxin IVA; -conotoxin MVIIC Delta opioid receptors (DORs) and their endogenous ligands Met-enkephalin and Leu-enkephalin have widespread and matching distributions in spinal cord pain-related primary sensory circuits of the rat, mouse, cat, and monkey in which they modulate the transmission of afferent nociceptive neural activity (Aronin et al., 1981; Dickenson et al., 1987; Miller and Seybold, 1989; Ramabandran et al., 1990; Levine et al., 1993; Standifer et al., 1994; Narita and Tseng, 1995) . Despite much progress, the cellular mechanism mediating DOR-induced modulation of neural transmission in sensory neurons remains to be clarified. Ever since the demonstration of enkephalin-induced inhibition of substance P release in sensory synapses (Jessell and Iversen, 1977) , later shown to involve DORs (Collin et al., 1991) , the dominant hypothesis has been that DORs inhibit C a 2ϩ influx to sensory neurons and, consequently, C a 2ϩ -dependent transmitter release. Several lines of evidence lend credence to the hypothesis of DOR-induced inhibition of C a 2ϩ influx. First, sensory neurons express DORs (Ji et al., 1995) and an assortment of high-voltageactivated C a 2ϩ channels (H VACC) Cardenas et al., 1995; Rusin and Moises, 1995) . Second, DOR activation by enkephalins presynaptically inhibits the transmission of painrelated activity in the spinal cord (Dickenson et al., 1987; Glaum et al., 1994 ) and brain , as well as the paininduced release of substance P (Zachariou and Goldstein, 1996) . Third, DORs localize in presynaptic terminals of spinal cordprojecting sensory neurons (Cheng et al., 1995; van Bockstaele et al., 1997) . Fourth, DORs inhibit HVACC currents in secretory (Albillos et al., 1996; Piros et al., 1996) and neuronal cell lines (Hescheler et al., 1987; McFadzean and Docherty, 1989; Toselli et al., 1997) . Indirect data suggested that DOR might inhibit Ca 2ϩ inward currents in sensory neurons as well (Shen and Crain, 1989) . However, more recent studies in those cells yielded negative results (Schroeder et al., 1991; Liu et al., 1995) . In this study, we reexamined this question and show that an enkephalin analog that acts on both pharmacological DOR subtypes (DORs-1 and DORs-2) (Reisine, 1995) consistently inhibited the HVACC current in all subpopulations of postnatal rat sensory neurons in culture. The low overall frequency of responding cells and the involvement of a previously untested DOR subtype (DOR-2) may explain previous negative results (Schroeder et al., 1991; Liu et al., 1995) .
DORs targeted L, N, P, and Q HVACC current types as defined by their sensitivity to nimodipine, -conotoxin-GVIA (-CTx-GVIA), -agatoxin-IVA (-Aga-IVA), and -conotoxin-MVIIC (-CTx-MVIIC), respectively (Llinás et al., 1989; Mintz et al., 1992; Randall and Tsien, 1995; McDonough et al., 1996) . The inhibition of the HVACC current types mediating transmitter release (N, P, and Q) in primary sensory affer-ents (Yu et al., 1992; Gruner and Silva, 1994 ) and brain (Reuter, 1996) validates the hypothesis that DORs may control synaptic transmission by reducing C a 2ϩ influx. In addition, the data suggest a broad influence of DORs in C a 2ϩ -dependent cellular processes linked to specific H VACC, such as sensory neuron development and survival and gene expression (Finkbeiner and Greenberg, 1996; Reuter, 1996; Hardingham et al., 1997) .
MATERIALS AND METHODS
Cell culture and immunoc ytochemistr y. All procedures were in strict accordance with the Guide for the C are and Use of Laboratory Animals, in agreement with the Society for Neuroscience Policy. Dorsal root ganglia (DRG) from the cephalic, thoracic, and lumbar regions were obtained from 5-to 11-d-old neonatal Sprague Dawley rats of either sex, decapitated under ether deep anesthesia, and kept at 4°C in HBSS until dissociated by enzymatic digestion with 0.25% trypsin and 0.5% collagenase for 30 min at 37°C, followed by gentle mechanical trituration using a fire-polished Pasteur pipette. After addition of 2 ml of culture media containing 10% fetal bovine serum (M EM10) to halt the enzymatic activity, the cell suspension was centrif uged at 2000 rpm for 5 min. The supernatant was discarded, and the pellet was resuspended in M EM10. Then, f urther mechanical dissociation was performed using Pasteur pipettes of increasingly smaller tip diameters. Once dissociated, the neurons were plated on coverslips coated with 0.25% collagen and 0.05% poly-D-lysine and kept at 36°C in M EM10 for 1 hr. Then, additional media was added to reach a final volume of ϳ2 ml in each culture dish. The culture media was always supplemented with penicillin -streptomycin (200 I U per 200 g /ml, respectively) to prevent bacterial -f ungal contamination.
The cells were maintained in an incubator at 36°C and 4% C O 2 until used for electrophysiology. No nerve growth factor was added to the media because postnatal sensory neurons do not require it for survival (Ruit et al., 1992) . To inhibit the proliferation of fibroblasts, 10 M ␤-D-arabinof uranoside cytokine was added to the culture media 24 hr after plating and then every 48 hr. The culture media was replaced by 50% every 48 hr. The cultures consisted of a mixed population of neurons of varied sizes. T ypically, the frequency of response to the agonist (inhibition of currents through C a 2ϩ channels) was low during the first 12 hr in culture, increased, and reached a peak and stabilized at 24 hr. Most recording experiments were done 12-48 hr after cell plating and always within 4 d in culture. C ells with no or minimal neurite development were used.
The immunocytochemistry experiments for labeling of substance P and ␣ 1C subunits of L -type C a 2ϩ channels used low-density cultures, following established protocols (C áceres et al., 1992) . In brief, cells were fixed with paraformaldehyde -sucrose for 20 min, washed with PBS, permeabilized with 0.2% Triton X-100 for 5 min, washed three times for 5 min with PBS, and incubated overnight with either a rat monoclonal antibody against substance P, clone NC1/34 (diluted 1:20), or a rabbit polyclonal antibody against the ␣ 1C subunit (diluted 1:100). The coverslips were incubated previously for 1 hr with 5% bovine serum albumin (BSA) to block nonspecific binding sites. An anti-rat IgG labeled with fit-C or an anti-rabbit IgG labeled with rhodamine were used as secondary antibodies in each case, with which the coverslips were incubated for 1 hr at room temperature. All antibodies were dissolved in 1% BSA. The procedure for immunodetection of ␣ 1C subunits was performed at 4°C to avoid protease-mediated digestion (Hell et al., 1993) . The coverslips were mounted on glass slides with FluorSave (C albiochem, La Jolla, CA), and observed 24 hr later with a fluorescein filter in a epifluorescence microscope (Axiovert TM35; Z eiss, Oberkochen, Germany).
Electrophysiolog y and data anal ysis. Coverslips containing neurons were removed from the incubator and placed into the recording chamber just before starting the electrophysiological experiments. Ba 2ϩ currents (I Ba ) flowing through H VACC were recorded at room temperature (20 -23°C) using the whole-cell configuration of the patch-clamp technique (Hamill et al., 1981) . The composition of the pipette solution was (in mM) 120 C sC l, 20 TEA-C l, 5 C l 2 Mg, 10 EGTA, 10 H EPES, 4 Na 2 ATP, 0.1 Li 2 GTP, and 0.1 leupeptin, pH adjusted to 7.4 with C sOH. T wo external solutions were used: a T yrode's solution containing (in mM) 135 NaC l, 2.5 KC l, 4 C aC l 2 , 2 MgC l 2 , 10 D-glucose, and 10 H EPES, pH adjusted to 7.4 with NaOH; and a Ba 2ϩ -containing solution, referred to as Ba-solution, containing (in mM) 5 BaC l 2 , 150 N-methyl-Dglucamine, 2 MgC l 2 , 10 D-glucose, and 10 H EPES, pH adjusted to 7.4 with HC l. The concentration of the charge carrier Ba 2ϩ was limited to 5 mM because higher concentrations can significantly interfere with toxin binding to H VACC (McDonough et al., 1996) .
The recordings were made with either an Axopatch 200A (Axon Instruments, Foster C ity, CA) or a List EPC -7 (Medical Systems, Greenvale, N Y) amplifier. Data acquisition was controlled with a desktop computer equipped with an analog-to-digital converter (Scientific Solutions, Solon, OH). The currents were low-pass filtered at 2 kHz, sampled at least at 10 kHz, and recorded on hard disk. The recording pipettes were made from thin-walled capillary glass (inner diameter of 1.0 mm; catalog #7052; Garner Glass Company, C laremont, CA) using a horizontal puller (P-97; Sutter Instruments, Novato, CA) and firepolished with a microforge (M-83; Narishige, Tokyo, Japan). When filled with internal solution, they had a resistance of 2-3 M⍀. The series resistance was compensated up to 70 -95%. No corrections for liquid junction potentials were made. Leak currents were subtracted on-line using a P/4 routine. When removed from the incubator and first placed in the recording chamber, the cells were bathed with the T yrode's solution and stayed in it until the whole-cell configuration was achieved. Then, the external solution was exchanged to the Ba-solution while holding the cell at Ϫ80 mV.
We required the data to meet three criteria to qualif y for f urther analysis: (1) negligible I Ba rundown over the entire duration of the experiment, (2) a f ully reversible agonist response, and (3) current waveforms free from artifacts indicative of poor space clamp, such as "notches" or slow components in the decay of capacitive currents. Unless otherwise noted, agonist and drug effects on I Ba were measured on current waveforms activated with 20 -50 msec command pulses to 0 mV from a holding potential (V H ) of Ϫ70 mV or more positive and delivered every 15-30 sec. The effects of the different drugs on the H VACC currents were quantified off-line using custom-made software by measuring the current amplitude at the end of the depolarizing test pulses.
Pharmacolog y. A small-volume (100 l) recording chamber was continuously perf used with control or drug-containing external solutions at an approximate rate of 0.6 ml /min using a system of multiple Teflon tubes connected to reservoirs containing the various solutions. All drugs were dissolved in the Ba-solution and were applied and removed by exchanging the external solution, which took ϳ15 sec. This relatively slow speed of solution exchange did not constitute an impediment because this work is not concerned with kinetic aspects. DORs were activated with the enkephalin analog [D-Ala 2 , D-Leu 5 ]-enkephalin (DADL E) (1 M), which nonselectively activates the DOR subtypes DORs-1 and DORs-2. [D-Pen 2 , D-Pen 5 ]-enkephalin (DPDPE) (1 M), and T yr-D-Ala-Phe-Glu-Val-Gly-N H 2 (deltorphin-II) (100 nM) were used as DOR-1-and DOR-2-selective agonists, respectively. The ␦-specific action of DADL E was tested with the highly selective DOR antagonist naltrindole (1 M). Mu opioid receptors (MORs) were activated with the selective agonist T yr-Pro-N-MePhe-D-Pro-N H 2 (PL O17) (1 M). Opioid agonists and antagonists were reconstituted from stock lyophilized frozen (Ϫ20°C) aliquots the day of the experiment. In some cases, unused solutions were refrozen to be used in the following experiment without loss of pharmacological potency. Ca 2ϩ channel-blocking drugs were applied at concentrations or in combinations that optimally targeted specific types of H VACC (10 M nimodipine, 2 M -conotoxin GV IA, 50 nM -agatoxin IVA, and 0.5-1 M -conotoxin M V IIC). We used two experimental protocols (protocol-1 and protocol-2) to estimate the contribution of a given pharmacological H VACC current type to I Ba and to the DADL Esensitive current (I D ). Protocol-1 tested the effect of DADL E on a specific H VACC current type, pharmacologically isolated by blocking all other current components with a mixture of drugs; a DADL E-induced inhibition of the isolated current indicated that it contributed to I D . This protocol was used to estimate the contributions to I D , as well as to I Ba , of H VACC current types for which no selective blockers are available (Qand R-types) and in addition to protocol-2 to gather complementary data on other current types. With protocol-1, the percentage contribution of a given H VACC current type to I D was equal to [(magnitude of inhibition during second agonist application / magnitude of inhibition during first agonist application) ϫ 100]. The tests for the contribution of Q-type current involved only one agonist application in the presence of C a 2ϩ channel blockers, and therefore the magnitude of the first inhibition was estimated from a separate, large number of cells. Protocol-2 measured the extent of agonist-induced I Ba inhibition before and after the blockade of a specific H VACC type; it was concluded that such current contributed to I D if its suppression reduced or occluded the agonist-induced inhibition. This protocol was used to evaluate the contributions of N-, P-, and L -type H VACC currents to I Ba and I D because those currents can be selectively inhibited by -conotoxin GV IA, -agatoxin IVA, and nimodipine, respectively. With protocol-2, the percentage contribution of a given H VACC current type to I D was equal to [(reduction of the current inhibition observed during second agonist application / magnitude of inhibition during first agonist application) ϫ 100].
The contribution of only one type of H VACC current to I D was tested in any given cell to limit agonist exposure to two applications: the first to obtain a control response, and the second to evaluate its reduction after the block of a specific H VACC current type. We chose this design because, in preliminary experiments, we found that I Ba inhibition and recovery became progressively smaller and slower, respectively, with repeated DADL E applications, and these changes started to be noticeable with the third agonist application.
The opioid agonists DADL E, DPDPE, and PL O-17 were from Peninsula Labs (Belmont, CA). -C T x-GV IA, -Aga-IVA, -C T x-M V IIC, and the rabbit polyclonal antibody against ␣ 1C subunits of L -type C a 2ϩ channels were from Alomone Labs (Jerusalem, Israel). Naltrindole, naloxone, and nimodipine were from Research Biochemicals (Natick, M A). The antibody against substance P was from Sera-Lab (Accurate Chemical & Scientific Corp., Westbury, N Y). Stock solutions of -CTx-GVIA, -Aga-IVA, and -C T x-M V IIC were prepared in water and stored at Ϫ20°C for no longer than 1 month. Nimodipine was diluted in methanol (1:2500) and stored in a light-proof container at Ϫ20°C. These aliquots were dissolved in external solution the day of the experiment. The fit-C -and rhodamine-conjugated secondary antibodies and the rest of the reagents were from Sigma (St. L ouis, MO). S-(Ϯ)-Bay-K 8644 was a gift of Dr. A. Hernández-Cruz (Instituto Fisiología C elular, Departamento Neurociencia, UNAM, M.F., México). Figure 1 A (lef t) shows representative traces of whole-cell barium currents (I Ba ) flowing through H VACC s in cultured postnatal DRG neurons (5-to 11-d-old), evoked at several membrane potentials from a holding potential (V H ) of Ϫ70 mV. The currents had an activation threshold and peak of approximately Ϫ30 and 0 mV, respectively ( Fig. 1 A, right) . The absence of an early inactivating component ( Fig. 1 A, lef t) and the lack of an extra current peak ("shoulder") at relative negative potentials in the currentvoltage ( I-V) curve ( Fig. 1 A, right) indicated a negligible lowthreshold T-type current contribution at this V H , as reported in these cells by others (Scroggs and Fox, 1991) .
RESULTS

DOR-mediated inhibition of HVACC currents
Bath application of 1 M DADLE, a DOR-preferring enkephalin analog (Bot et al., 1997 , and references therein) that mimics the action of natural enkephalins on synaptic transmission (Mulder et al., 1984) , reversibly inhibited I Ba in 37% of 457 cells tested 3-96 hr after plating. Figures 1 B and 3 , A and C, show actual records and the time course of the response. On average, 1 M DADLE inhibited 31.6 Ϯ 16.3% (n ϭ 168) of I Ba , as estimated from the current reduction at the end of the depolarizing test pulse.
I-V curves of I Ba obtained before and during DADLE application illustrate the agonist effect at the end of 25 msec voltage test pulses over a wide membrane potential range ( Fig. 1 B, right) . The inhibition was most conspicuous at the peak of the curve (0 mV), which did not apparently shift along the voltage axis, and became less obvious at depolarized potentials as a result of its voltage dependence. Whereas these data reflect the sum of effects of the agonist on the individual I-V curves of the potentially targeted HVACC components, it has been shown that neurotransmitters affect such curves in a similar way (Patil et al., 1996; Roche and Treistman, 1998) . We tested the agonist effect at 0 mV at the end of 20 -50 msec test pulses to clearly resolve the reduction in current magnitude induced by ␦ agonists. These measurements, however, overlook the maximal effect of the agonist, which occurs very early after the onset of the test pulse ( Fig.  1 B, trace D), and subtle differential effects of the agonist on the voltage dependence of individual current components.
The inhibited current exhibited a slow activation phase ( Fig.  1 B, trace D) that reflected the commonly observed voltage-and time-dependent removal of neurotransmitter-induced G-proteinmediated inhibition of non-L-type HVACC currents (Hescheler et al., 1987; Bean, 1989; Carbone and Swandulla, 1989; López and Brown, 1991; Kasai, 1992; Rusin and Moises, 1995; Albillos et al., 1996; Wiley et al., 1997) . The voltage dependence of the DADLE-induced inhibition was further confirmed by showing that a depolarizing prepulse to 40 mV, preceding the test pulse, partially removed the inhibition observed at 0 mV (Fig. 1C ). On average, the prepulse recovered 39.3 Ϯ 6.2% (n ϭ 10) of the DADL E-sensitive current (I D ).
The frequency of responding cells varied among the subpopulations recognized in vitro but not with postnatal age (P5-P11) or animal sex. Grouped according to the diameter of their roundshaped soma (Gilabert and McNaughton, 1997) , small (Ͻ15 m), medium (15-26 m), and large (Ͼ26 m) neurons contributed 58, 26, and 9%, respectively, to the total population in vitro. DADLE inhibited I Ba in 19 (n ϭ 77), 35 (n ϭ 197), and 18% (n ϭ 84) of the cells in those groups, respectively (Fig. 2 A) . In addition, we identified a novel subpopulation of medium-sized neurons featuring an unmistakable "pear-shaped" cell body of ϳ15 ϫ 26 m, which we will refer to as P-neurons after their distinctive morphology. They represented the 7% of the population in culture and were found at all postnatal ages examined (P5-P11) in similar proportions in cephalic, middle, and caudal DRGs. In sharp contrast to the other cell types, DADL E inhibited I Ba in 75% (n ϭ 84) of the P-neurons (Fig. 2 A) .
The unusual morphology of P-neurons did not appear to result from the dissociation process, culture conditions, or cell injury. First, their shape was maintained in long-term cultures (up to 12 d). Second, they exhibited f unctional and morphological properties of healthy neurons, such as the expression of several types of voltage-dependent ion currents (Na ϩ , K ϩ , and C a 2ϩ ), and the development of axons when maintained in culture for several days. Third, they were present in cultures growing on three different substrates (poly-D-lysine plus collagen, poly-D-lysine, or laminin), maintained in either defined media or media supplemented with serum. Interestingly, every single P-neuron in culture showed intense somatic immunoreactivity for the painrelated peptide substance P (Fig. 2 C) .
The enkephalin analog DADLE has a remarkable high affinity for DORs and interacts with both known pharmacological DOR subtypes (Xu et al., 1998) . A series of experiments showed that DORs mediated the DADLE-induced HVACC current inhibition. First, naltrindole (1 M), a highly selective DOR antagonist (Rogers et al., 1990; Reisine, 1995) , powerfully blocked the effect of DADLE (Fig. 3A) in cells previously shown to be sensitive to the enkephalin agonist. The current traces of Figure 3A (right) show one of several tests (n ϭ 5) in which 1 M naltrindole completely prevented the DADLE-induced inhibition. Never did DADLE inhibit more than 5% of I Ba in the presence of naltrindole, which by itself had no effect on I Ba . The lack of DADLE effect in the presence of naltrindole was not caused by receptor desensitization (McFadzean and Docherty, 1989; Motin et al., 1995) . To avoid desensitization of the DOR-mediated response, the DOR agonist was applied, at most, twice and just long enough to achieve a maximal effect (1.5-2 min). Desensitization was negligible with such procedure as revealed by the essentially similar inhibitions during two consecutive control DADLE applications (Fig. 3B ). Naloxone (2 M), a nonselective opioid receptor antagonist, also blocked the DADLE-induced I Ba inhibition (data not shown). Second, in DADLE-responsive cells, the DOR-2-selective agonist deltorphin-II (100 nM), but not the DOR-1-selective agonist DPDPE (1 M), mimicked the DADLE-induced HVACC current inhibition (n ϭ 5), independently of the order of application (Fig. 3C) . The smaller inhibition observed with deltorphin-II could have resulted from the use of a 10-fold smaller concentration (100 nM) or differences in the mode of action of the agonists. At such a concentration, on the other hand, only DORs-2 were probably activated. For example, deltorphin-II is 900 times more selective for DORs-2 than opioid agonists (Buzas et al., 1992) , also known to inhibit Ca 2ϩ currents in sensory neurons (Rusin and Moises, 1995) . Conversely, for achieving 50% of the effect of 1 M [D-Ala 2 -N-MePhe 4 -Glycol 5 ]-enkephalin (DAMGO) (a opioid receptor agonist) on synaptic currents in spinal cord, a 100-fold larger concentration of deltorphin-II was required (Glaum et al., 1994) . The deltorphin-II-induced HVACC current inhibition and the lack of DPDPE effect were confirmed in several other cells in which those agonists were tested individually (n ϭ 5 and 6, respectively). Third, whenever DADLE was ineffective, neither deltorphin-II nor DPDPE were effective in experiments in which either all three agonists (n ϭ 8) or DADLE and DPDPE (n ϭ 5) were tested sequentially in the same cell. This excluded the possibility that the DOR-2-selective agonist inhibited I Ba via receptors not activated by DADLE. The lack of DPDPE effect was consistent with previous reports (Schroeder et al., 1991) . The involvement of DORs-2, on the other hand, may explain why DOR-mediated HVACC modulation passed previously unnoticed.
Because DADLE could potentially interact with MORs (Goldstein and Naidu, 1989), we ran experiments to assess the involvement of that receptor in the DADLE response. The irreversible MOR antagonist ␤-funaltrexamine (␤-FNA) (5-10 M) (Takemori et al., 1981) had no effect on the DADLE response (n ϭ 5) (Fig. 4 A) . The slightly smaller inhibition during the second DADLE application (Fig. 4 A) was attributable to DADLE acting on an initially smaller agonist-sensitive current because of a matching deficit in current recovery after the first agonist expo- sure or because of a possible modest DOR block by ␤-FNA (Hayes et al., 1985) . As a result, I D decreased to 89.5 Ϯ 5.4% of control (n ϭ 5) during the second DADL E application. As noted by Schroeder et al. (1991) , the current inhibition observed during ␤-FNA application results from a opioid agonist activity of ␤-FNA (Takemori et al., 1981) and served as a positive control for the effectiveness of that drug. The highly selective MOR agonist PL O17 could reversibly inhibit the H VACC current in cells in which DADL E was ineffective (n ϭ 6) (Fig. 4 B) . This showed that PL O17, but not DADL E, activated MORs, a finding replicated in several other neurons. Similarly, DAMGO, but not DADL E or DPDPE, inhibited K ϩ currents in hippocampal neurons (Moore et al., 1994) . Lastly, both DADL E and deltorphin-II responses desensitized if those agonists were present in the bathing solution for over 1 min once the inhibition of HVACC currents reached a stable level (data not shown). In contrast, the MOR-mediated H VACC current inhibition does not desensitize (Schroeder et al., 1991) . Finally, the overall low frequency of cells responding to DADL E (37%) was much smaller than that of sensory neurons responding to MOR activation (90%) (Schroeder et al., 1991; Rusin and Moises, 1995) . Together, our data strongly indicate that DORs, but not MORs, mediate the DADL E-induced H VACC current inhibition and suggest that DORs-2 are probably involved.
It is unlikely that kappa opioid receptors (KORs) mediated the DADL E effect because the irreversible -mediated inhibition caused by ␤-FNA did not occlude or reduce the DADLE response (Fig. 4 A) , and the affinity of DADLE for KORs is four orders of magnitude smaller than that for DORs (Goldstein and Naidu, 1989) .
HVACC currents in postnatal sensory neurons
The contributions of L-, N-, P-, and Q-type HVACC currents to I Ba were estimated as the current fractions blocked by 10 M nimodipine, 2 M -CTx-GVIA, 50 nM -Aga-IVA, and 0.5-1 M -CTx-MVIIC, respectively (Llinás et al., 1989; Regan et al., 1991; Randall and Tsien, 1995; McDonough et al., 1996) . Figure  5A summarizes the data. A current fraction (5.6 Ϯ 2.2%; n ϭ 5) remained unblocked in the presence of all drugs together and will be referred to as R-type (Randall and Tsien, 1995) . Cd 2ϩ (300 M) completely blocked it, indicating that it was carried by voltage-activated Ca 2ϩ channels (data not shown). Consistent with reports showing that postnatal sensory neurons in vitro express all HVACC current types (Scroggs and Fox, 1991; Moises et al., 1994; Rusin and Moises, 1995) , any given Ca 2ϩ channel blocker always inhibited a fraction of the total whole-cell I Ba in every single neuron tested.
The average L-type (18.2 Ϯ 4.5%; n ϭ 10) and N-type (48.5 Ϯ 11.5%; n ϭ 8) contributions to I Ba agreed very well with published data in these cells [L ϭ 15%; N ϭ 42% (Rusin and Moises, 1995) ; and L ϭ 18%; N ϭ 43% ]. The effect of -CTx-GVIA was essentially irreversible (Fig. 5B) , ruling out a potential block of L-type currents by that drug reported to be reversible and to require a much larger concentration (Williams Figure 3 . DOR involvement in the DADL E-induced inhibition of I Ba . A, Plot of time course (lef t) and I Ba current records (right) corresponding to open symbols of an experiment testing the effect of the highly selective DOR antagonist naltrindole (Nti) on the DADL E-induced inhibition. I Ba was elicited with 60 msec pulses to 0 mV from a V H of Ϫ70 mV. The data points in the plot correspond to I Ba values at the end of the test pulses. The control current (trace CON ) was powerf ully inhibited by 1 M DADL E (trace D), and the inhibition f ully reversed upon agonist washout (trace W ). DADL E was completely ineffective when subsequently coapplied with 1 M naltrindole (trace DϩNti). The lack of DADL E effect in the presence of naltrindole was not attributable to response desensitization ( B) . B, The responses to short (1.5-2 min) applications of DADL E, as used in our experiments, were not affected by desensitization. Two applications of DADL E of 2 min each, separated by an interval of 3-5 min, caused a similar amount of I Ba inhibition in control cells (n ϭ 3), as illustrated by the plot of the ratio of the magnitudes of the second to the first I Ba inhibition (essentially 1). Ratios in the individual cells were 0.93, 0.95, and 0.99. C, Time course (lef t) and current records (right) of an experiment in which the DOR-2-selective agonist deltorphin-II (100 nM) mimicked the DADL E-induced inhibition (traces 1-3) of I Ba in a reversible way (trace 3-5). Current records correspond to similarly numbered data points in the time course plot. As in other four cells, 1 M DPDPE (a DOR-1-selective agonist) had no effect on I Ba (trace 6 ). In this cell, DADLE and deltorphin-II (Delt-II ) reduced 1.4 and 1.02 nA of I Ba , respectively. et al., 1992). We defined the P-type fraction as that blocked with 50 nM -Aga-IVA, a concentration that maximally inhibits P-type Ca 2ϩ channels in cerebellar and peripheral sensory neurons (Mintz and Bean, 1993; Tottene et al., 1996) and spares other HVACC currents Rusin and Moises, 1995) . The average P-type contribution was 14.2 Ϯ 9.1% (n ϭ 15). Others estimated a larger P-type contribution with 200 nM -Aga-IVA (23% in Mintz et al., 1992; 24% in Rusin and Moises, 1995) , a result that we replicated with that concentration (25.2 Ϯ 8.4%; n ϭ 6). However, we used 50 nM -Aga-IVA to define the P-type contribution because higher concentrations could also affect Q-type channels (IC 50 of ϳ90 nM) (Randall and Tsien, 1995) .
-Aga-IVA did not affect N-or L-type currents. Thus, the average current inhibition obtained with 50 nM -Aga-IVA plus 2 M -CTx-GVIA together (61%; n ϭ 3; 53, 62, and 68% in each individual cell) was similar to the sum (62%) of the inhibitions obtained separately with each toxin (14% with 50 nM -Aga-IVA; 48% with 2 M -CTx-GVIA), indicating that those drugs, at those concentrations, inhibited separate Ca 2ϩ channel populations. Accordingly, a much higher -Aga-IVA concentration did not affect the L current in central and peripheral sensory neurons .
The pharmacological identification of the Q-type current relied on its blockade by -CTx-MVIIC, a drug that can also block -CTx-GVIA-sensitive N-type channels and -Aga-IVAsensitive P-type channels in rat neurons (Randall and Tsien, 1995; McDonough et al., 1996) . Therefore, we followed the standard procedure of measuring the effect of -CTx-MVIIC on the current remaining after blocking the non-Q-and non-R-type currents with 10 M nimodipine, 2 M -CTx-GVIA, and 50 nM -Aga-IVA (Fig. 5C ) (Randall and Tsien, 1995; Rusin and Moises, 1995; McDonough et al., 1996) . The time needed for the drug mixture to reach a stable effect varied among cells (3-7 min), reflecting the relatively slow speed of bath solution exchange and cell-to-cell variability. Subsequently, -CTx-MVIIC caused a partial and irreversible inhibition (Hillyard et al., 1992; Rusin and Moises, 1995) . The average Q fraction estimated with 0.5-1 M -CTx-MVIIC was 16.1 Ϯ 3.4% (n ϭ 4), somewhat larger than that of DRG neurons from older rats (P14 -P28; 10%) (Rusin and Moises, 1995) and smaller than that of rat cerebellar neurons (35%) (Randall and Tsien, 1995) . As in other work (Randall and Tsien, 1995) , 0.5 M -CTx-MVIIC caused a saturating effect, although the inhibition reached a plateau sooner with 1 M (1.5 vs 3 min).
HVACC current types inhibited by DORs
A second series of experiments determined which HVACC current types were inhibited by DADLE and their fractional contribution to I D . The data are from neurons in which the HVACC current showed negligible rundown over the entire experiment, and the DADLE-induced inhibition was fully reversible. We found that the DOR-mediated I Ba inhibition targeted all HVACC current types. The average contributions of the L-, N-, P-, and Q-type HVACC currents to I D were 18.7 Ϯ 5.3% (n ϭ 8), 50.1 Ϯ 11.7% (n ϭ 6), 26.2 Ϯ 6.5% (n ϭ 8), and 19.6 Ϯ 3.3% (n ϭ 5), respectively. These values correspond to DADLE inhibiting 32.5, 32.6, 58.3, and 38.5% of L-, N-, P-, and Q-type currents, respectively. No differences were apparent between the various sensory subpopulations. The total sum of percentages in excess of 100% may reflect either the different expression levels of HVACC current types in neurons of different sizes (Scroggs and Fox, 1991) or less than perfect toxin selectivity. Figure 5A ( N) , 50 nM -Aga-IVA ( P), and 0.5-1 M -CTx-MVIIC ( Q), respectively. Because of its lack of selectivity, -CTx-MVIIC was applied after N-, P-, and L -type currents were all previously blocked. The R-type was defined as the fraction that remained unblocked in the presence of all above drugs ( R) and was f ully blocked by C d 2ϩ . Solid bars show the average Ϯ SEM contributions of each current type to the DADLE-sensitive current (I D ). Notice the large contribution of the P-type current to I D despite its relatively small contribution to I Ba . B, Plot of I Ba versus time before and after the application of 2 M -CTx-GVIA. The data points represent values of I Ba at the end of 40 msec depolarizing test pulses to 0 mV from a V H of Ϫ70 mV. The -CTx-GVIA-induced inhibition stabilized within 2 min and was essentially irreversible (tested up to 20 min). In this neuron, the N-type current contributed 40% of I Ba . To better visualize the toxin effect, the ordinate axis was truncated. Data from a medium-sized, round neuron. C, Time course from an experiment testing the contribution of the Q-type current to I Ba , which was evoked with 20 msec test pulses. The L, N, and P currents contributing to the initial I Ba were blocked by a combination (Drug Mi x) of 10 M nimodipine, 2 M -CTx-GVIA, and 50 nM -Aga-IVA. The fraction subsequently inhibited by 0.5 or 1 M -CTx-MVIIC (1 M in this cell) was defined as Q-type. The time course graph plots the values of I Ba at the end of the test pulses. The current remaining unblocked was defined as R-type. Data from a P-neuron. All measures made at the end of voltage test pulses to 0 mV from a V H of Ϫ70 mV. DADL E-induced inhibition. Analogously, no matter how small the magnitude of the ␦ opioid inhibition was, any given HVACC current type tested (except the R-type) was always found to contribute to I D . Representative data for each H VACC current type will be reported separately below.
L-type current
Both protocol-1 (n ϭ 3) and protocol-2 (n ϭ 5) indicated that the L-type H VACC current contributed to I D . Figure 6 A shows time course data (lef t) and actual current records (right) from a representative cell tested with protocol-1. A first application of 1 M DADL E inhibited 0.95 nA (63%) of the control I Ba in a fully reversible way (Fig. 6 A, B, traces 1-3) . The combined application of 2 M -CTx-GVIA, 50 nM -Aga-IVA, and 1 M -CTx-MVIIC inhibited the non-L -and non-R-type currents (1.18 nA; 81%) (Fig. 6 A, B, traces 3, 4 ) . A second application of DADLE reversibly inhibited 0.16 nA of the remaining current, presumably consisting only of L -and R-type components (Fig. 6 A, B, traces 4 -6) . Because the R-type current was agonist-insensitive ( Fig.  6G ) (n ϭ 2), we concluded that DADL E inhibited the L-type component. The magnitudes in the reduction of I D after blocking the L-type or other current types in the experiments reported below (at least 19%) are incompatible with desensitization (at most 7%) (Fig. 3B ). Electrophysiological and immunocytochemical data support our assumption that the current fraction remaining in the presence of 2 M -CTx-GVIA, 50 nM -Aga-IVA, and 1 M -CTx-MVIIC contained an L-type component. All types of sensory neurons in culture always express a nimodipinesensitive L-type component (Kostyuk et al., 1988; Cardenas et al., 1995; Rusin and Moises, 1995) . Consistently, we found that a highly specific antibody against rat and mouse ␣ 1C subunits of neuronal L-type HVACC (Hell et al., 1993) strongly labeled the soma of every single sensory neuron in culture, in ϳ500 cells examined (Fig. 6 E) .
The contribution of L-type current to I D was further validated by using protocol-2. In this case, a first application of DADLE reversibly inhibited 1.3 nA of I Ba (29%) (Fig. 6C,D) . After reversal of the agonist effect, application of the L-type channel blocker nimodipine (10 M) inhibited 36% of I Ba (1.59 nA). A second application of DADLE, in the continuous presence of nimodipine, only inhibited 0.74 nA. Because the suppression of the nimodipine-sensitive fraction reduced the amount of current inhibited by DADLE, we again concluded that I D had an L HVACC current component. Lastly, the L-type current agonist Bay-K 8644 (10 M) (Fox et al., 1987) increased the current remaining in the presence of -CTx-GVIA, -Aga-IVA, and -CTx-MVIIC, indicating the presence of an L-type component in the drug mixture-insensitive fraction (Fig. 6F) . DADLE reduced the enhanced current to an amplitude smaller than that before Bay-K 8644 application (Fig. 6 F, trace MϩBϩD) . Together, our results strongly support that the L-type current con- Figure  6 . DOR-mediated inhibition of the dihydropyridine-sensitive L -type current. Data points in A and C represent values of I Ba at the end of 25 msec test pulses to 0 mV from a V H of Ϫ70 mV. A, Time course of an experiment testing the L -type current contribution to I D with protocol-1. The first DADL E application reversibly inhibited 63% of I Ba . Subsequently, the block of N-, P-, and Q-type currents with 2 M -CTx-GVIA, 50 nM -Aga-IVA, and 1 M -CTx-MVIIC (Drug Mix) inhibited 81% of I Ba . The contribution of the L -type current to I D was revealed by a second DADL E application, which inhibited 53% of the non-N, non-P, and non-Q currents in a f ully reversible way. B, Current records corresponding to similarly numbered data points in A. C, Time course of an experiment testing the L -type contribution to I D with protocol-2. The block of the L-type current fraction (36% in this cell) with 10 M nimodipine reduced the amount of I Ba inhibited by 1 M DADLE. The second DADL E application was done in the continuous presence of nimodipine. D, Current records corresponding to similarly numbered data points in C. The current reversibly inhibited by DADL E decreased from 1.3 to 0.74 nA after blocking the L -type current with 10 M nimodipine. E, All sensory neurons in culture, regardless of cell subpopulation, were immunoreactive for the ␣ 1C subunit of neuronal C a 2ϩ channels, indicating the presence of L -type H VACC in these cells. Neurons obtained from 5-d-old postnatal animals. P-neurons in the culture are labeled with arrows. Scale bar, 20 m. F, The control H VACC current (trace C), activated by voltage pulses to 0 mV from a V H of Ϫ70 mV, was partially blocked by a mixture of 2 M -CTx-GVIA, 50 nM -Aga-IVA, and 1 M -CTx-MVIIC, which was kept in the bath for the rest of the experiment (trace M ). S-(Ϯ)-Bay-K 8644 (10 M) increased the amplitude of the drug mixtureresistant current (trace MϩB), and the subsequent application of 1 M DADL E in the continuous presence of Bay-K 8644 reduced the enhanced current (MϩBϩD). The magnitude of the inward current in the presence of DADL E was smaller than that before S-(Ϯ)-Bay-K 8644 application. G, The R-type current, defined as the current remaining unblocked in the presence of a mixture of 10 M nimodipine, 2 M -CTx-GVIA, 50 nM -Aga-IVA, and 1 M -CTx-MVIIC (trace M ), was completely insensitive to DADL E (trace MϩD). The agonist reversibly inhibited I Ba before the application of the drug mixture (traces C, D, W ). Data from a P-neuron.
tributes to I D . The average contribution, estimated from data obtained with protocols-1 and -2, was 18.7 Ϯ 5.3% (n ϭ 8). Figure 7 , A and B, shows representative data on the contribution of N-type channels to I D obtained with protocol-2. In this example, the first DADL E application reversibly reduced I Ba by 0.35 nA (traces 1-3) , amounting to an inhibition of 13% of the control current. Trace 4 shows the current that remains after the selective inhibition of the N-type fraction with 2 M -CTx-GVIA. The irreversible -CTx-GVIA-induced block reached a plateau within 2 min. In the neuron of Figure 7 , the -CTx-GVIAsensitive N-type current amounted to 1.4 nA and therefore contributed 67% of the total I Ba . Blockade of this fraction caused a reduction of the I Ba inhibition by a second DADL E application, which reduced the non-N-type current by 0.18 nA in a fully reversible manner (traces 5, 6 ). The N-type current contribution to I D ranged from 31 to 69% in different cells, with an average of 50.1 Ϯ 11.7% (n ϭ 6). The average does not include one cell in which the contribution of N-type current to I D was particularly large (84%). That case shows, however, that no matter how large a contribution a given current type made to I D , it never accounted for the totality of it.
N-type current
P-type current
The P-type current contributed to I D in all tested neurons (n ϭ 8). Representative data, obtained with protocol-2 in a P-neuron, are illustrated in Figure 7 , C and D. In the absence of the toxin, DADLE reversibly reduced I Ba by 1.2 nA, which represented a 34% inhibition of the control current (Fig. 7C, traces 1-3, D) . After recovery of I Ba upon agonist washout, bath application of 50 nM -Aga-IVA inhibited 0.43 nA (11.8%) of the current when measured at the end of the 25 msec voltage test pulse (Fig. 7C,D,  trace 4 ) . A second application of DADLE, done in the presence of the toxin to ensure no recovery of P-type current, reduced I Ba by only 0.72 nA (Fig. 7C,D, trace 5) . In this cell, the -Aga-IVAsensitive current contributed 35.8% of I D . Similar results were observed in all tested cells, indicating that P-type HVACC are targeted by DORs. The average P-type contribution to I D was 26.2 Ϯ 6.5% (n ϭ 8), ranging from 13.4 to 35.8% in different cells. Interestingly, in the cell of Figure 7 , C and D, as well as in five of eight other cells tested, DADLE appeared to inhibit the entire P-type fraction, because the absolute reduction in I Ba inhibition after the block of the P-type current (0.48 nA) (Fig. 7D, trace 5 ) almost exactly agreed with the amount of current inhibited by the toxin (0.43 nA) (Fig. 7D, trace 4 ) . However, this finding should be (traces 1-3) . After the application of 2 M -CTx-GVIA, which inhibited 1.4 nA of I Ba (trace 4 ), a second DADLE application reversibly inhibited 0.18 nA of the remaining non-N current (traces 4 -6 ). C, Time course of an experiment testing the P-type current contribution to I D . The data points represent values of I Ba at the end of 25 msec voltage test pulses to 0 mV from a V H of Ϫ70 mV. The block of the P-type current fraction (11.8% in this cell) with 50 nM -Aga-IVA reduced the amount of I Ba inhibited by 1 M DADL E. The toxin was present throughout the second DADL E application because its effect was partially reversible. D, Current records corresponding to similarly numbered data points in C. The first DADLE application reversibly inhibited 1.2 nA of the total I Ba (traces 1-3) , whereas the second agonist application, after the block of the P-type current, suppressed only 0.72 nA of the non-P I Ba (traces 4 -6 ). Because the magnitude of the inhibited I Ba was larger during the second (trace 5) than during the first DADL E application (trace 2), the effect of DADL E deceptively appeared to be smaller than predicted from the loss of target, -Aga-IVA-sensitive P-type channels. This occurred because the second DADL E application was tested on the larger preagonist current (trace 3 vs trace 1) resulting from the over-recovery of I Ba during reversal of the first DADLE-induced inhibition (trace 3; see data points in C). When allowances are made for this change in the basal I Ba , the reduction in DADL E-induced inhibition can be entirely accounted for by the suppression of P-type target channels. E, F, Time course and corresponding traces from a representative experiment in a round neuron, using protocol-1 to test the contribution of Q-type HVACC current to I D . The numbered points in E correspond to similarly numbered traces in F. N-, P-, and L-type HVACC currents were inhibited by perf using the cell with a solution containing 2 M -CTx-GVIA, 50 nM -Aga-IVA, and 10 M nimodipine (Drug Mi x; traces 1, 2 in F ). DADL E reversibly inhibited a fraction of the remaining non-N, non-L, and non-P currents (traces 2, 3 in F ). This inhibition was f ully reversible (trace 4 in F ). The data points are the values of I Ba at the end of 20 msec voltage test pulses to 0 mV from a V H of Ϫ70 mV.
interpreted cautiously because the small contribution of the P-type current to the total H VACC current could lead to uncertainties in these measurements.
Q-type current
Data gathered with protocol-1, which assessed the effect of a single application of DADL E after the non-Q-and non-R-type currents were previously inhibited with 10 M nimodipine, 2 M -CTx-GVIA, and 50 nM -Aga-IVA, indicated that the Q current contributed to I D . Figure 7 shows representative time course data ( E) and current records ( F). The blocker mixture (Drug Mi x) inhibited ϳ86% of the total I Ba of this cell. A subsequent application of 1 M DADL E, in the continuous presence of the blockers, reversibly inhibited 0.18 nA (61%) of the remaining current (Fig. 7 E, F, traces 2-4 ), which includes a DADL E-insensitive R fraction. These data indicated that Q-type HVACC were also a target of the DOR-mediated inhibition and were replicated in four other cells. In the example of Figure 7 , E and F, the contribution of the Q-plus -R type currents to I Ba was 14% (from the current remaining after applying the drug mixture), and the amount of Q-type current inhibited by DADLE represented 8% of the initial I Ba . On average, these quantities, in five cells, were 22 Ϯ 11 and 6 Ϯ 2%, respectively. Subtracting the previously estimated R fraction (5.6%) to the R plus Q fraction (22%) yields a Q fraction (16.4%) that closely agrees with that directly estimated (16.1%). Because in this series of experiments DADL E was applied only once, the average contribution of the Q-type current to I D (19.6 Ϯ 3.3%; n ϭ 5) was estimated with respect to the average magnitude of I D , previously measured in 168 cells.
DISCUSSION
DOR-mediated HVACC current inhibition
This work represents the first demonstration that DORs inhibit HVACC currents in sensory neurons. It validates a cellular mechanism long suspected to mediate the inhibitory effects of ␦ opioids on synaptic transmission and pain sensation in sensory circuits (Jessell and Iversen, 1977; Dickenson et al., 1987; Collin et al., 1991; Glaum et al., 1994; Z achariou and Goldstein, 1996) . Our finding that DORs target several types of H VACC currents further suggests that they could broadly affect H VACC -mediated Ca 2ϩ signaling in neurons. Substantial evidence supports the existence of two pharmacological subtypes of DORs, termed DORs-1 and DORs-2 (Sofuouglu et al., 1991; Mattia et al., 1992; Bilsky et al., 1996; Reisine, 1995) . The DADL E-induced inhibition of the H VACC current implicates DORs because the highly selective DOR antagonist naltrindole (Stewart and Hammond, 1994) f ully blocks it. Deltorphin-II, a natural compound exquisitely selective for DORs-2 (Erspamer et al., 1989) , mimics the DADLE effect, whereas a DOR-1 agonist has no effect. These results indicate a primary role of DORs-2 in the inhibitory effect of DADLE. Like the endogenous enkephalins, DADL E has a very high affinity for either native DOR subtypes, as well as the cloned DOR (categorized as DORs-2) (K ieffer et al., 1992; Raynor et al., 1994; Wang et al., 1996; Xu et al., 1998) . The ability of DADL E to inhibit Ca 2ϩ currents entirely via DORs is patently shown in NG108 -15 cells, which express only those opioid receptors (Tsunoo et al., 1986; Hescheler et al., 1987; McFadzean and Docherty, 1989) . In nonsensory neurons, DADL E and Leu-enkephalin produce similar inhibitory effects via DOR on C a 2ϩ and K ϩ currents (Moore et al., 1994; Motin et al., 1995) . Because it was observed only in DADLE-responsive cells, the deltorphin-II effect necessarily involves receptors that sustained the DADLE response. Recent reports implicating DORs-2 as the most important DOR subtype modulating peripheral nociception (Tseng et al., 1994; Negri et al., 1995) further emphasizes the potential physiological relevance of our results.
As in previous work, the commonly used DOR-1 agonist DPDPE was ineffective (Schroeder et al., 1991; Moises et al., 1994; Liu et al., 1995) . Because this compound inhibits HVACC currents in nonsensory neurons and non-neuronal cells (Motin et al., 1995; Nah et al., 1997; Toselli et al., 1997) , DORs-1 could be implicated in such cases. However, a potential involvement of DORs-2 cannot as yet be dismissed because some cross-reactivity of DPDPE with DORs-2 has been recognized in vivo and in vitro (Vanderah et al., 1994; Wang et al., 1996; Toll et al., 1997) . The involvement of an untested DOR subtype could explain why other studies in sensory neurons missed the ␦ opioid modulation of Ca 2ϩ currents (Schroeder et al., 1991; Moises et al., 1994; Liu et al., 1995) , although the age of experimental subjects (5-to 11-d-old here vs 21-d-old or older in other studies) and the overall low frequency of DOR-responding cells might have contributed as well.
In contrast to DORs, MORs seem neither necessary nor sufficient for the inhibition of the HVACC current by DADLE. The response occurred normally after the irreversible block of MORs, whereas it was completely blocked in the presence of an antagonist highly specific for DOR. The observed DADL E effect does require receptors other than MORs because cells showing a robust MOR-induced inhibition of the HVACC current did not respond to DADLE. Conversely, DADLE, but not an MOR agonist, inhibited K ϩ and Ca 2ϩ currents in single neurons expressing both DORs and MORs (Moore et al., 1994; Motin et al., 1995) . Other significant differences distinguish the DORmediated DADLE effect from the HVACC current inhibition attributable to MORs (Schroeder et al., 1991; Rusin and Moises, 1995) . First, only DADLE inhibited L-type currents. Second, the MOR response does not desensitize, whereas we and others found that the DOR-mediated DADLE response does (McFadzean and Docherty, 1989; Motin et al., 1995) . Third, MORs inhibit the HVACC current in 90% of sensory neurons, whereas a substantially smaller overall proportion responds to DADLE (37%).
DORs-2 appear to be the only receptors that could by themselves mediate the inhibitory effect of the enkephalin analog on the HVACC current. However, it is important to note that the data are certainly compatible with a collective participation of more than one receptor in the production of the final cellular response. This seems indeed a reasonable expectation in view of the fact that DADLE, as well as the natural enkephalins, can interact with DORs-1, DORs-2, and MORs (Goldstein and Naidu, 1989; Negri et al., 1995) . Testing this hypothesis will require a detailed study of the effect of different combinations and doses of selective opioid agonists on the various HVACC currents.
DOR-mediated inhibition of multiple HVACC current types
A major conclusion of this study is that DORs inhibit basically all pharmacological components (L, N, P, Q) of the HVACC current of immature postnatal sensory neurons, with the sole exception of the R fraction. A similar pattern has been reported for MORs (Schroeder et al., 1991; Rusin and Moises, 1995) and KORs (Wiley et al., 1997) , although those receptors do not target L-type currents. In addition, we report here for the first time the inhibition of neuronal P-currents by DORs. Our data are consistent with results obtained in neuroblastoma (Morikawa et al., 1995; Toselli et al., 1997) and chromaffin (K leppisch et al., 1992; Albillos et al., 1996) cells. From the diversity of H VACC targets, DORs can be expected to activate membrane-delimited pathways leading to non-L -type channel inhibition by G-protein ␤␥ subunits (Walker and DeWaard, 1998) and also to generate cytosolic messengers implicated in L -type current modulation (Mathie et al., 1992; C ardenas et al., 1997) . This complex machinery mediating DOR effects is only partially understood (Hescheler et al., 1987; Taussig et al., 1992; Laugwitz et al., 1993; Piros et al., 1996) . N-, P-, and Q-type H VACC were implicated in transmitter release in sensory neurons (Yu et al., 1992; Gruner and Silva, 1994 ) and brain (Reuter, 1996) . If the modulation demonstrated here in neurite-free cells also takes place in nerve endings, then our data could account for the presynaptic inhibitory effects of ␦ opioids on the conduction of nociceptive impulses in the spinal cord and brain (Jessell and Iversen, 1977; Dickenson et al., 1987; Collin et al., 1991; Glaum et al., 1994; Wang et al., 1996; Zachariou and Goldstein, 1996) . In this respect, anatomical work has clearly shown that DORs are located in presynaptic terminals of spinal cord-projecting neurons (Cheng et al., 1995; van Bockstaele et al., 1997) and thus optimally placed to modulate synaptic Ca 2ϩ influx. As a rule, neurotransmitters never completely inhibit Ca 2ϩ currents, although the degree of inhibition may vary widely depending on the channel's phosphorylation state, isoforms, constituent subunits, and interaction with G-proteins (Swartz, 1993; Zhang et al., 1996; Z amponi, 1997; Roche and Treistman, 1998; Walker and DeWaard, 1998) . In consonance with such an empirical "rule," DADL E only partially inhibits the L -, N-, and Q-type components. The P current, in contrast, appeared to be fully inhibited in most cells (Fig. 7C,D) , a result that suggested a more effective f unctional coupling between DORs and those channels.
Neither the imperfect selectivity of -Aga-IVA nor the limited precision of our quantitative measurements could entirely account for this finding, which was also reflected, in an independent manner, by the comparatively larger average P-type fraction in I D . Thus, whereas L, N, and Q proportions in I D and I Ba closely agreed (18:18, 50:48, and 19:16, respectively) , the P fraction in I D almost doubled its fraction in I Ba (26:14) . The ability of inhibiting L currents singles out DORs from most receptors because non-L -type current modulation is quite common, whereas L -type currents are rarely targeted in all neuronal types so far examined (Z hu and Ikeda, 1993; Amico et al., 1995; Boehm and Huck, 1996; Foehring, 1996; Viana and Hille, 1996) . Interestingly, DOR-induced inhibition of L -type HVACC is found elsewhere only in secretory cells in which those channels mediate the C a 2ϩ influx needed for exocytosis (pituitary: Lightman et al., 1982; Al Z ein et al., 1984; GH3: Piros et al., 1996; chromaffin: K leppisch et al., 1992; Albillos et al., 1996) . Our data and the evidence of C a 2ϩ -dependent exocytosis of substance P from sensory neuron somata (Huang and Neher, 1996) raise the interesting possibility, even if highly speculative, that a mechanism of DOR-modulated secretion involving L -type HVACC might be conserved across neuronal and non-neuronal cells. DOR modulation of somatic C a 2ϩ influx, via L -or non-L-type HVACC, could also potentially affect C a 2ϩ -dependent gene expression and neuron development (Murphy et al., 1991; Finkbeiner and Greenberg, 1996; Hardingham et al., 1997) .
One should expect DORs to affect the transmission of diverse sensory modalities as a result of targeting various subpopulations of DRG neurons (Perl, 1992) . Conduction along P-neurons might be particularly affected as they are preferentially targeted. From their size and substance P content, they could be grouped with nociceptive, slow-conducting neurons (Harper and Lawson, 1985; Cardenas et al., 1995; Gilabert and McNaughton, 1997) . However, their unmistakable morphology has not been noted previously, and thus they are likely to represent a separate, novel subpopulation.
